The survey also noted that 34% of firms require lifestyle or clinical support programs in order for employees to receive GLP-1 agonists for weight loss.
Careful plan design, managing high-cost categories and leveraging alternative approaches can help employers contain costs while avoiding wholesale disruptions and maintaining overall employee engagement.
The 2026 Segal Health Plan Cost Trend Survey reports that "double-digit" increases in the cost of pharmacy benefits are driving up the price of healthcare for employers.
An original author of the Affordable Care Act explores what the new federal push to lower prescription drug prices could do—and what it may be missing.
GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the same path, this expert writes.
That is the million-dollar question facing HR. Experts explore how trends in the use of GLP-1s for weight management are massively disrupting the benefits landscape.
